Testing fresh frozen plasma for traumatic brain injury
Treatments studied
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests whether giving fresh frozen plasma (a blood product) soon after a traumatic brain injury can help people recover better. It is for adults aged 18 to 65 with moderate to severe TBI confirmed by CT scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have a moderate to severe traumatic brain injury (GCS score between 3 and 12)
- A CT scan shows specific brain injury patterns (BIG 3)
- You can receive the treatment within 1 hour of arriving at the hospital
- You have no history of serious heart, kidney, liver, or lung problems
- You have never had a bad reaction to plasma or blood products
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with severe traumatic brain injury (TBI) who already need brain pressure or oxygen monitoring. Doctors want to see if certain tests can help predict how well someone might recover.
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
This trial tests whether giving a platelet transfusion to patients with severe traumatic brain injury who are on antiplatelet medication can improve how well their blood clots. You may qualify if you have a serious brain bleed and are taking a medication like aspirin or clopidogrel.
This trial tests giving a blood clotting medicine called fibrinogen to adults with severe bleeding from trauma before they reach the hospital. The goal is to see if it helps control bleeding and improve outcomes.
This trial tests a treatment called INTERCEPT Fibrinogen Complex (IFC) to help control bleeding in trauma patients. It is given to patients who arrive at the hospital quickly after injury and have low fibrinogen levels.
Hear when a new Moderate to Severe Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.